DICHALCOGENIDE PRODRUGS
    1.
    发明公开

    公开(公告)号:EP4071148A1

    公开(公告)日:2022-10-12

    申请号:EP21167187.0

    申请日:2021-04-07

    摘要: The present application relates to a compound having the formula (I)

             A-L-B     (I)

    wherein
    A is represented by

    L is a bond or a self-immolative spacer; and
    B is represented by

    or

    The compound is capable of releasing molecular cargo in the presence of a reductase and is thus suitable for diagnosing or quantifying the activity of the reductase and for treating, ameliorating, preventing or diagnosing a disorder selected from a neoplastic disorder; atherosclerosis; an autoimmune disorder; an inflammatory disease; a chronic inflammatory autoimmune disease; ischaemia; and reperfusion injury.